Tesla shares fell more than 4% on Wednesday morning, threatening the EV maker's blistering rebound out of a prolonged slump.

Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...

Investing.com -- William Blair remains optimistic on Tesla (NASDAQ: TSLA) despite recent setbacks, forecasting that shares ...

In a noteworthy financial move, William Blair Investment Management LLC has escalated its holdings in Live Nation Entertainment, Inc. (NYSE: LYV) by an impressive 18.7% in the fourth quarter, as ...

William Blair restated their outperform rating on shares of Neurogene (NASDAQ:NGNE – Free Report) in a report published on ...

Fintel reports that on March 24, 2025, William Blair downgraded their outlook for AZEK (NYSE:AZEK) from Outperform to Market ...

Stock analysts at William Blair increased their Q1 2025 earnings estimates for Boeing in a research report issued on ...

In a report released today, Sami Corwin from William Blair reiterated a Buy rating on Neurogene (NGNE – Research Report). The company’s shares ...

William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process benefits from low expenses across its parent firm's funds, whose fees rank in their respective ...

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Ross Stores (ROST – Research Report) and ...

Emerging markets present a landscape of opportunity for equity investors despite macroeconomic headwinds. Click to read.

The Fund seeks long-term capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of equity securities, including common ...